Global Marine Biotechnology Market

Marine Biotechnology Market Size, Share, Growth Analysis, By Product(Marine animal-derived products, marine plant-derived products, and marine microbial-derived products), By Application(Healthcare and cosmetics, food and agriculture, industrial products, and research and development), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35H2077 | Region: Global | Published Date: March, 2024
Pages: 219 | Tables: 64 | Figures: 75

Marine Biotechnology Market Insights

Global Marine Biotechnology Market size was valued at USD 5.8 billion in 2022 and is poised to grow from USD 6.19 billion in 2023 to USD 10.49 billion by 2031, growing at a CAGR of 6.80% during the forecast period (2024-2031).

The global marine biotechnology market is a rapidly growing industry that is focused on utilizing the vast resources of the world's oceans for the development of new products and solutions in various fields such as medicine, agriculture, and energy. The purpose of this market is to harness the unique and diverse properties of marine organisms to create novel biotechnological products, including therapeutics, nutraceuticals, and biofuels, among others. The market is driven by the increasing demand for sustainable and eco-friendly products, the rising prevalence of chronic diseases, and the need for alternative sources of energy. Despite the vast potential of marine biotechnology, there are also several key restraints that limit its growth, such as the high cost of research and development, limited access to marine resources, and regulatory hurdles. However, recent advancements in biotechnology and genomics, as well as the increasing number of collaborations between industry players and research organizations, are expected to drive the growth of this market in the coming years. One of the key trends in the market is the growing use of marine-derived enzymes in various industrial applications, such as food processing, pulp and paper manufacturing, and biofuel production. In addition, there is also an increasing focus on marine biomaterials, which have a wide range of potential applications in areas such as medicine, tissue engineering, and regenerative medicine. As the global population continues to grow and the demand for sustainable products increases, the marine biotechnology market is expected to present numerous opportunities for growth and innovation.

US Marine Biotechnology Market is poised to grow at a sustainable CAGR for the next forecast year.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Marine Biotechnology Market size was valued at USD 5.8 billion in 2022 and is poised to grow from USD 6.19 billion in 2023 to USD 10.49 billion by 2031, growing at a CAGR of 6.80% during the forecast period (2024-2031).

Marine Biotechnology Market is highly competitive, with a number of key players operating in the market. Some of the major players in the market are focusing on various strategies such as partnerships, collaborations, mergers and acquisitions, and new product launches to gain a competitive edge in the market. For instance, in February 2021, Lonza Group Ltd. acquired HansaBioMed Life Sciences Ltd. to expand its capabilities in the development and production of biological therapeutics. Moreover, several research institutions and universities are also actively involved in marine biotechnology research and development, leading to the creation of new companies and startups in the market. The growing number of research activities in the field is expected to drive innovation and competitiveness in the market. 'BASF SE (Germany)', 'CP Kelco (US)', 'Cyanotech Corporation (US)', 'DowDuPont Inc. (US)', 'FMC Corporation (US)', 'Lonza Group AG (Switzerland)', 'Marinova Pty Ltd (Australia)', 'New England Biolabs Inc. (US)', 'Novozymes A/S (Denmark)', 'PML Applications Ltd (UK)', 'PharmaMar S.A. (Spain)', 'Seppic (France)', 'Solutex GC (Spain)', 'Sonneborn LLC (US)', 'The Lubrizol Corporation (US)', 'The Scottish Association for Marine Science (UK)', 'Thermo Fisher Scientific Inc. (US)', 'Tiger Brands Limited (South Africa)', 'Unilever NV (Netherlands)', 'Xiamen Kingdomway Group Co. Ltd. (China)'

With the increasing awareness of environmental concerns and sustainability, there is a growing demand for eco-friendly products across various industries. Marine biotechnology offers a range of sustainable and eco-friendly solutions, such as marine-derived enzymes for industrial applications, biofuels, and bioplastics. For instance, a company called Algix produces bioplastic materials from algae, which are biodegradable and sustainable alternatives to traditional plastic materials.

Marine Biomaterials - The use of marine-derived biomaterials is an emerging trend in the marine biotechnology market, with numerous potential applications in the fields of medicine, tissue engineering, and regenerative medicine. For instance, marine collagen has been shown to have superior properties compared to mammalian collagen and is being explored as a potential biomaterial for use in wound healing and tissue regeneration.

North America dominated the marine biotechnology market, owing to its well-developed infrastructure and favorable government initiatives to promote the use of marine resources in biotechnology research. The United States is the largest market in this region, with a significant number of marine biotechnology companies and research organizations.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Marine Biotechnology Market

Report ID: SQMIG35H2077

$5,300
BUY NOW GET FREE SAMPLE